JW Pharmaceutical Corporation (001067.KS)

59,000.00 -500.00 (-0.84%) At close: 03:30PM KST

JW Pharmaceutical Corporation

JW Gwacheon Tower, 38
Gwacheon-daero 7-gil Gyeonggi-do
Gwacheon-si 13840
South Korea
82 2 8406 777
https://www.jw-pharma.co.kr

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Young-Sub Shin	CEO, Head of Sales & Marketing and Inside Director	N/A	N/A	1963
Sung-Yeol Lee	CEO, Head of Product Development & Management and Director	N/A	N/A	N/A
Jae-Kwang Jeon	Head Managing Director and Head of Public Relation	N/A	N/A	1962
Mr. Hyun-seok Han	Head of Product Plant	N/A	N/A	1962
Kim Yong Kwan	Development Head & Internal Director	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.

Corporate governance

JW Pharmaceutical Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.